In silico screening of potent inhibitors against COVID-19 key targets from a library of FDA-approved drugs.

Elmorsy, Mohammad A; El-Baz, Ahmed M; Mohamed, Nashwa H; Almeer, Rafa; Abdel-Daim, Mohamed M; Yahya, Galal

Elmorsy, Mohammad A; El-Baz, Ahmed M; Mohamed, Nashwa H; Almeer, Rafa; Abdel-Daim, Mohamed M; Yahya, Galal.

Afiliación

Elmorsy MA; Department of Pharmaceutical Organic Chemistry, Faculty of Pharmacy, Mansoura University, Mansoura, 35516, Egypt.
El-Baz AM; Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, 11152, Egypt.
Mohamed NH; Department of Microbiology and Biotechnology, Faculty of Pharmacy, Delta University for Science and Technology, Gamasa, 11152, Egypt. Elbaz_pharmacy@yahoo.com.
Almeer R; Hospitals of Zagazig University, Zagazig, Al Sharqia, 44519, Egypt.
Abdel-Daim MM; Department of Zoology, College of Science, King Saud University, P.O. Box 2455, Riyadh, 11451, Saudi Arabia.
Yahya G; Department of Zoology, College of Science, King Saud University, P.O. Box 2455, Riyadh, 11451, Saudi Arabia.

Environ Sci Pollut Res Int ; 29(8): 12336-12346, 2022 Feb.

Article en En | MEDLINE | ID: mdl-34562220

Asunto(s)

COVID-19; Preparaciones Farmacéuticas; Antivirales/farmacología; Reposicionamiento de Medicamentos; Humanos; Simulación del Acoplamiento Molecular; SARS-CoV-2

Palabras clave

Angiotensin receptor blockers; COVID-19; Drug repurposing; Heartburn; Molecular docking; Oral antiseptics

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Preparaciones Farmacéuticas / COVID-19 Tipo de estudio: Diagnostic_studies / Screening_studies Límite: Humans Idioma: En Revista: Environ Sci Pollut Res Int Asunto de la revista: SAUDE AMBIENTAL / TOXICOLOGIA Año: 2022 Tipo del documento: Article País de afiliación: Egipto Pais de publicación: Alemania

Texto completo

Añadir a Mi BVS

Imprimir

XML

PubMed Links

Buscar en Google